BackEU lists rare nerve disorder as side-effect of J&J Covid vaccine
1 min read
22 Jul 2021, 11:16 PM IST
'After assessing the available data, PRAC considered that a causal relationship between COVID-19 vaccine Janssen and GBS is possible,' the European Medicines Agency said
PremiumEurope's medicines regulator said on Thursday it had added a rare nerve-degenerating disorder, Guillain-Barré syndrome, as a possible rare side effect from Johnson & Johnson's COVID-19 vaccine after it reviewed 108 cases reported worldwide.
"After assessing the available data, PRAC considered that a causal relationship between COVID-19 vaccine Janssen and GBS is possible," the European Medicines Agency said, referring to its safety committee, PRAC.
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!
Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint.
Download The Mint News App to get Daily Market Updates.
More
Less
Published: 22 Jul 2021, 11:15 PM IST
Next Story
